This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Spectrum Pharmaceuticals Inc (SPPI)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -62.13M 94.54M 48.52M -48.84M
Operating Gains/Losses 0.00 132.00K 38.00K 11.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 42.56M -33.50M -30.90M -12.75M
(Increase) Decrease in Inventories 1.57M -734.00K -7.85M -1.05M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -23.90M 24.79M 16.07M 21.55M
(Decrease) Increase In Other Current Liabilities 425.00K -6.37M 3.05M -47.00K
(Increase) Decrease In Other Working Capital 20.50M 1.21M 834.00K 17.46M
Other Non-Cash Items 9.41M 19.15M 27.29M 9.07M
Net Cash From Continuing Operations -2.09M 71.96M 43.29M -22.54M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -2.09M 71.96M 43.29M -22.54M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 72.46M 157.00K 0.00
Purchases of Property, Plant & Equipment -3.16M -312.00K -475.00K -1.58M
Acquisitions -11.17M -158.70M 0.00 0.00
Purchases of Short-Term Investments 0.00 -26.43M -17.03M -40.65M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -14.33M -114.69M 746.00K -9.83M
Issuance of Debt 220.00M 125.00M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 16.68M 6.51M 30.60M 3.63M
Repayment of Long-Term Debt -175.00M -50.01M 0.00 0.00
Repurchase of Capital Stock -28.85M -10.49M -2.93M 0.00
Payment of Cash Dividends 0.00 -9.01M 0.00 0.00
Other Financing Charges, Net 2.43M -976.00K -4.06M -29.00K
Net Cash From Financing Activities 35.26M 61.02M 23.61M 3.60M
Effect of Exchange Rate Changes -2.23M 202.00K 0.00 0.00
Net Change in Cash & Cash Equivalents 16.61M 18.50M 67.64M -28.78M

SPPI Spectrum Pharmaceuticals Inc

Analysts Ratings for SPPI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 1
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

SPPI Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs